Randomized Controlled Trials May Be Less Burdensome, FDA Guidance Says
This article was originally published in The Gray Sheet
Executive Summary
Randomized controlled clinical trials of medical devices represent, in certain circumstances, the least burdensome route for sponsors to gain FDA approval, the agency maintains.